Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | OKN-007 |
Synonyms | |
Therapy Description |
OKN-007 is a small molecule nitrone inhibitor that can cross the blood brain barrier, and may result in anti-inflammatory and apoptotic activity (PMID: 26248280, PMID: 31628293). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
OKN-007 | OKN007|OKN 007 | OKN-007 is a small molecule nitrone inhibitor that can cross the blood brain barrier, and may result in anti-inflammatory and apoptotic activity (PMID: 26248280, PMID: 31628293). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT05518838 | Expanded access | OKN-007 | Expanded Access to OKN-007 for Patients With Diffuse Midline Glioma, H3 K27-altered | No longer available | USA | 0 |
NCT05561374 | Phase I | OKN-007 | Study of Safety and Pharmacokinetic Properties of Oral OKN-007 in Patients With Recurrent High-Grade Glioma | Active, not recruiting | USA | 0 |
NCT01672463 | Phase I | OKN-007 | Clinical Trial of IV OKN-007 in a Pilot Cohort of Human Recurrent Malignant Glioma Patients | Active, not recruiting | USA | 0 |